ACS Publications. Most Trusted. Most Cited. Most Read
Mycobacterium tuberculosis PptT Inhibitors Based on Heterocyclic Replacements of Amidinoureas
My Activity

Figure 1Loading Img
    Letter

    Mycobacterium tuberculosis PptT Inhibitors Based on Heterocyclic Replacements of Amidinoureas
    Click to copy article linkArticle link copied!

    • Samantha Ottavi
      Samantha Ottavi
      Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
    • Kelin Li
      Kelin Li
      Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
      More by Kelin Li
    • Jackson G. Cacioppo
      Jackson G. Cacioppo
      Department of Chemistry, UNC College of Arts and Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
    • Andrew J. Perkowski
      Andrew J. Perkowski
      Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
    • Remya Ramesh
      Remya Ramesh
      Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
      More by Remya Ramesh
    • Ben S. Gold
      Ben S. Gold
      Department of Microbiology & Immunology, Weill Cornell Medicine, New York, New York 10065, United States
      More by Ben S. Gold
    • Yan Ling
      Yan Ling
      Department of Microbiology & Immunology, Weill Cornell Medicine, New York, New York 10065, United States
      More by Yan Ling
    • Julia Roberts
      Julia Roberts
      Department of Microbiology & Immunology, Weill Cornell Medicine, New York, New York 10065, United States
    • Amrita Singh
      Amrita Singh
      Department of Microbiology & Immunology, Weill Cornell Medicine, New York, New York 10065, United States
      More by Amrita Singh
    • David Zhang
      David Zhang
      Department of Microbiology & Immunology, Weill Cornell Medicine, New York, New York 10065, United States
      More by David Zhang
    • John Mosior
      John Mosior
      Departments of Biochemistry and Biophysics, Texas Agricultural and Mechanical University, College Station, Texas 77843, United States
      More by John Mosior
    • Laurent Goullieux
      Laurent Goullieux
      Evotec ID (Lyon), SAS 40 Avenue Tony Garnier, 69001 Lyon, France
    • Christine Roubert
      Christine Roubert
      Evotec ID (Lyon), SAS 40 Avenue Tony Garnier, 69001 Lyon, France
    • Eric Bacqué
      Eric Bacqué
      Evotec ID (Lyon), SAS 40 Avenue Tony Garnier, 69001 Lyon, France
      More by Eric Bacqué
    • James C. Sacchettini
      James C. Sacchettini
      Departments of Biochemistry and Biophysics, Texas Agricultural and Mechanical University, College Station, Texas 77843, United States
    • Carl F. Nathan*
      Carl F. Nathan
      Department of Microbiology & Immunology, Weill Cornell Medicine, New York, New York 10065, United States
      *Email: [email protected]
    • Jeffrey Aubé*
      Jeffrey Aubé
      Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
      Department of Chemistry, UNC College of Arts and Sciences, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States
      *Email: [email protected]
    Other Access OptionsSupporting Information (1)

    ACS Medicinal Chemistry Letters

    Cite this: ACS Med. Chem. Lett. 2023, 14, 7, 970–976
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acsmedchemlett.3c00162
    Published June 26, 2023
    Copyright © 2023 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    4′-Phosphopantetheinyl transferase (PptT) is an essential enzyme for Mycobacterium tuberculosis (Mtb) survival and virulence and therefore an attractive target for a tuberculosis therapeutic. In this work, two modeling-informed approaches toward the isosteric replacement of the amidinourea moiety present in the previously reported PptT inhibitor AU 8918 are reported. Although a designed 3,5-diamino imidazole unexpectedly adopted an undesired tautomeric form and was inactive, replacement of the amidinourea moiety afforded a series of active PptT inhibitors containing 2,6-diaminopyridine scaffolds.

    Copyright © 2023 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Supporting Information

    Click to copy section linkSection link copied!

    The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsmedchemlett.3c00162.

    • Additional and extended data tables, biological methods, and compound synthesis and characterization (PDF)

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!
    Citation Statements
    Explore this article's citation statements on scite.ai

    This article is cited by 5 publications.

    1. Terry W. Moore, (Editorial Advisory Board, ACS Medicinal Chemistry Letters)William C. K. Pomerantz (Topic Editor, ACS Medicinal Chemistry Letters). Celebrating the 60th Anniversary of the MIKIW Meeting-in-Miniature: Virtual Special Issue. Journal of Medicinal Chemistry 2024, 67 (9) , 6895-6896. https://doi.org/10.1021/acs.jmedchem.4c00716
    2. Terry W. Moore, (Editorial Advisory Board, ACS Medicinal Chemistry Letters)William C. K. Pomerantz (Topic Editor, ACS Medicinal Chemistry Letters). Celebrating the 60th Anniversary of the MIKIW Meeting-in-Miniature: Virtual Special Issue. ACS Medicinal Chemistry Letters 2024, 15 (5) , 565-566. https://doi.org/10.1021/acsmedchemlett.4c00139
    3. Beatriz M. Rocha, Eugénia Pinto, Emília Sousa, Diana I. S. P. Resende. Targeting Siderophore Biosynthesis to Thwart Microbial Growth. International Journal of Molecular Sciences 2025, 26 (8) , 3611. https://doi.org/10.3390/ijms26083611
    4. Amrita Singh, Samantha Ottavi, Inna Krieger, Kyle Planck, Andrew Perkowski, Takushi Kaneko, Andrew M. Davis, Christine Suh, David Zhang, Laurent Goullieux, Alexander Alex, Christine Roubert, Mark Gardner, Marian Preston, Dave M. Smith, Yan Ling, Julia Roberts, Bastien Cautain, Anna Upton, Christopher B. Cooper, Natalya Serbina, Zaid Tanvir, John Mosior, Ouathek Ouerfelli, Guangli Yang, Ben S. Gold, Kyu Y. Rhee, James C. Sacchettini, Nader Fotouhi, Jeffrey Aubé, Carl Nathan. Redirecting raltitrexed from cancer cell thymidylate synthase to Mycobacterium tuberculosis phosphopantetheinyl transferase. Science Advances 2024, 10 (11) https://doi.org/10.1126/sciadv.adj6406
    5. Zhen-Xi Niu, Ya-Tao Wang, Jin-Feng Sun, Peng Nie, Piet Herdewijn. Recent advance of clinically approved small-molecule drugs for the treatment of myeloid leukemia. European Journal of Medicinal Chemistry 2023, 261 , 115827. https://doi.org/10.1016/j.ejmech.2023.115827

    ACS Medicinal Chemistry Letters

    Cite this: ACS Med. Chem. Lett. 2023, 14, 7, 970–976
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acsmedchemlett.3c00162
    Published June 26, 2023
    Copyright © 2023 American Chemical Society

    Article Views

    1350

    Altmetric

    -

    Citations

    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.